BCAL Diagnostics Limited (AU:BDX) has released an update.
BCAL Diagnostics Limited shareholders showed robust support during their recent General Meeting, passing all resolutions, including share issuance and director participation in placements. With a strong turnout and the Chair’s discretionary votes cast in favor, the company secured a clear mandate for its proposed actions.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
